Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bayview Acquisition | BAYAU | Jan 22, 2025 | 10.81 | 0.00 |
BBB Foods | TBBB | Jan 22, 2025 | 30.29 | +1.20 |
BCB Bank | BCBP | Jan 22, 2025 | 11.58 | -1.03 |
BCE | BCE | Jan 22, 2025 | 23.15 | -1.03 |
Beachbody A | BODI | Jan 22, 2025 | 6.71 | +0.30 |
Beacon Roofing Supply | BECN | Jan 22, 2025 | 116.54 | +0.42 |
Beam Global | BEEM | Jan 22, 2025 | 2.82 | -4.08 |
Beam Therapeutics | BEAM | Jan 22, 2025 | 26.39 | +7.58 |
Beamr Imaging | BMR | Jan 22, 2025 | 4.02 | +4.69 |
Beasley Broadcast A | BBGI | Jan 22, 2025 | 8.40 | -1.75 |
Beazer Homes USA | BZH | Jan 22, 2025 | 28.00 | -0.67 |
Becton, Dickinson And Co | BDX | Jan 22, 2025 | 237.92 | -1.02 |
BeiGene ADR | ONC | Jan 22, 2025 | 222.22 | +1.61 |
Bel Fuse A | BELFA | Jan 22, 2025 | 88.59 | -0.02 |
Bel Fuse B | BELFB | Jan 22, 2025 | 82.23 | -0.24 |
Belden | BDC | Jan 22, 2025 | 122.07 | +1.13 |
Belgium Investable Mkt Idx MSCI Ishares | EWK | Jan 22, 2025 | 18.29 | -0.83 |
Belite Bio ADR | BLTE | Jan 22, 2025 | 58.91 | +1.19 |
Bellevue Life Sciences Acquisition | BLAC | Jan 22, 2025 | 11.93 | +5.07 |
Bellevue Life Sciences Acquisition Unit | BLACU | Jan 22, 2025 | 11.89 | 0.00 |
BellRing Brands | BRBR | Jan 22, 2025 | 76.23 | +0.49 |
Belpointe Prep A | OZ | Jan 22, 2025 | 61.00 | -1.13 |
Benchmark Electronics | BHE | Jan 22, 2025 | 48.86 | -0.22 |
Beneficient A | BENF | Jan 22, 2025 | 0.64 | +1.34 |
Benitec Biopharma | BNTC | Jan 22, 2025 | 10.69 | -0.74 |
Benson Hill | BHIL | Jan 22, 2025 | 1.72 | 0.00 |
Bentley Systems B | BSY | Jan 22, 2025 | 46.56 | +0.82 |
Berkshire Hathaway A | BRK-A | Jan 22, 2025 | 691 500.00 | -1.57 |
Berkshire Hathaway B | BRK-B | Jan 22, 2025 | 460.51 | -1.72 |
Berkshire Hills Bancorp | BHLB | Jan 22, 2025 | 28.20 | -1.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.